4//SEC Filing
Moran Kevin Patrick 4
Accession 0001209191-23-038417
CIK 0001347178other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:34 PM ET
Size
5.8 KB
Accession
0001209191-23-038417
Insider Transaction Report
Form 4
Moran Kevin Patrick
SVP, CFO & Treasurer
Transactions
- Sale
Common Stock
2023-06-15$6.29/sh−16,000$100,710→ 122,926 total
Holdings
- 635(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.23 to $6.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001806596
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:34 PM ET
- Size
- 5.8 KB